Raymond James Financial Services Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Raymond James Financial Services Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,555	Closed	-$207K	–	3463
2022 Q1	$207K	Sell	2,555 -2,825	-53%	-$239K	﹤0.01%	2951
2021 Q4	$552K	Sell	5,380 -63	-1%	-$6.05K	﹤0.01%	2335
2021 Q3	$476K	Buy	+5,443	New	+$493K	﹤0.01%	2391
2020 Q4	–	Sell	-5,038	Closed	-$268K	–	3112
2020 Q3	$268K	Buy	+5,038	New	+$300K	﹤0.01%	2342

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial Services Advisors's SYNH Position: Q2 2022 in Review

Raymond James Financial Services Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 2,555 shares — an estimated $207K sold.

Raymond James Financial Services Advisors first reported a position in SYNH in Q3 2020 and held it in 4 quarters. The position peaked at $552K in Q4 2021. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

Raymond James Financial Services Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Raymond James Financial Services Advisors sold 2,555 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $207K.
Raymond James Financial Services Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2020 and held it in 4 quarters.
Raymond James Financial Services Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $552K in Q4 2021.
362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.